Skip to content
  • ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • COMMENTARY
        • PRESS RELEASES
        • VIDEOS
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • EARMARK DATABASE
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Pharmaceuticals

General Waste, Healthcare, Intellectual Property, Medicare, Pharmaceuticals

Biden Price Controls Kill Innovation and Patients

October 6, 2023 Christina Smith

 IRA drug price controls will devastate future drug development, resulting in more lives lost.

General Waste, Healthcare, Medicare, Pharmaceuticals

Congress Should not Double Down on Devastating Drug Price Controls

August 1, 2023 Christina Smith

House Democrats’ new bill on price controls will devastate future drug development and raise costs. 

Biopharmaceuticals, General Waste, Healthcare, Intellectual Property, Pharmaceuticals, Regulations

Biden’s Budget and the SMART Prices Act Will Devastate Drug Development

June 24, 2023 Thomas Schatz

Pharmaceutical price controls in President Biden’s budget and the SMART Choices Act will devastate drug development.

General Waste, Healthcare, Pharmaceuticals

Patients Pay the Ultimate Price for Price Controls

February 17, 2023 Christina Smith

Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices. 

Citizens Against Government Waste Releases Analysis of Minnesota Opioid Tax
340B, General Waste, Government Waste, Healthcare, Oversight, Pharmaceuticals

New Study Confirms 340B Program is Exploited

December 3, 2021 Elizabeth Wright

A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.

Biopharmaceuticals, Biosimilars, Budget, General Waste, Healthcare, Obamacare, Pharmaceuticals

Salvage the Good from the Healthcare Debacle

August 1, 2006 Thomas Schatz

The healthcare reform juggernaut, arguably the most radical attempt to remake the economy and the nation’s healthcare infrastructure in history, was supposed to have flown through Congress before the August recess with nary a peep.  Instead, as Americans have gotten wind of its alarming provisions and exorbitant costs, the plan appears to be fizzling fast in the summer heat.

Posts pagination

Previous 1 2

Search

Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

  • ABOUT
  • WASTEWATCHER
  • MEDIA CENTER
  • ISSUES
  • ITPC
  • CCAGW
  • 1-800-USA-DEBT ®
  • MEDIA@CAGW.ORG
  • 317 MASSACHUSETTS AVENUE, N.E.
    SUITE 300
    WASHINGTON, D.C. 20002

© Citizens Against Government Waste